AstraZeneca

AstraZeneca
Favicon Fierce Pharma

AZ to build cell therapy supply hub, R&D center in Shanghai

The move positions the British drugmaker as the first multinational pharma company to boast end-to-end cell therapy capabilities in China.
Angus Liu Mar 19, 2026 10:20am
FDA conference hall

FDA to end 9-month adcomm hiatus with review of AZ cancer drugs

Mar 6, 2026 11:16am
more expensive

China is no longer licensing 'bargain basement': analyst

Feb 24, 2026 5:07pm
Fly fishing

Evinova reels in AI partnerships with Astellas and AZ deals

Feb 24, 2026 12:00pm
obesity overweight weight loss weigh

AstraZeneca's oral GLP-1 scored phase 2 wins, but no data yet

Feb 10, 2026 9:58am
change direction new plan alter arrows move reprioritize

AstraZeneca relaxed about relaxin drug's poor efficacy in ph. 2

Feb 10, 2026 7:50am